Design of acid-activated cell penetrating peptide for delivery of active molecules into cancer cells

Bioconjugate Chemistry

Volumn 22, Issue 7, 2011, Pages 1410-1415

  Zhang, Wei ^a   Song, Jingjing ^a   Zhang, Bangzhi ^a   Liu, Liwei ^a   Wang, Kairong ^a   Wang, Rui ^a,b  

^a LANZHOU UNIVERSITY   (China)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CONTROLLED DRUG DELIVERY; CYTOTOXICITY; DISEASES; PEPTIDES; TARGETED DRUG DELIVERY;

ACTIVE MOLECULES; CAMPTOTHECINS; CANCER CELLS; CELL-PENETRATING PEPTIDE; DRUG DELIVERY APPLICATIONS; MEMBRANE TRANSLOCATION; PH VALUE; PH-DEPENDENT; PHYSIOLOGICAL CONDITION; SOLID TUMORS;

AMINO ACIDS;

ACID ACTIVATED CELL PENETRATING PEPTIDE; CAMPTOTHECIN; CELL PENETRATING PEPTIDE; HISTIDINE; LYSINE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL; CELL PH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG UPTAKE; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS;

EID: 79960598683     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc200138d     Document Type: Article

References (30)

1. Ojima, I. (2008) Guided molecular missiles for tumor-targeting chemotherapy-case studies using the second-generation taxoids as warheads Acc. Chem. Res. 41, 108-119
2. Low, P. S., Henne, W. A., and Doorneweerd, D. D. (2008) Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases Acc. Chem. Res. 41, 120-129
3. Scholler, N., Fu, N., Yang, Y., Ye, Z., Goodman, G. E., Hellström, K. E., and Hellström, I. (1999) Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma Proc. Natl. Acad. Sci. U. S. A. 96, 11531-11536 (Pubitemid 29487415)
4. Fox, E. J., Salk, J. J., and Loeb, L. A. (2009) Cancer genome sequencing-an interim analysis Cancer Res. 69, 4948-4950
5. Vaupel, P., Kallinowski, F., and Okunieff, P. (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review Cancer Res. 49, 6449-6465 (Pubitemid 20008770)
6. Gerweck, L. E. and Seetharaman, K. (1996) Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer Cancer Res. 56, 1194-1198 (Pubitemid 26080953)
7. Lee, E. S., Gao, Z., and Bae, Y. H. (2008) Recent progress in tumor pH targeting nanotechnology J. Controlled Release 132, 164-170
8. Tannock, I. F. and Rotin, D. (1989) Acid pH in tumors and its potential for therapeutic exploitation Cancer Res. 49, 4373-4384 (Pubitemid 19208329)
9. Makovitzki, A., Fink, A., and Shai, Y. (2009) Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides Cancer Res. 69, 3458-3463
10. An, M., Wijesinghe, D., Andreev, O. A., Reshetnyak, Y. K., and Engelman, D. M. (2010) pH-(low)-insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation Proc. Natl. Acad. Sci. U. S. A. 107, 20246-20250
11. Na, K., Lee, E. S., and Bae, Y. H. (2007) Self-organized nanogels responding to tumor extracellular pH: pH-dependent drug release and in vitro cytotoxicity against MCF-7 cells Bioconjugate Chem. 18, 1568-1574 (Pubitemid 47464066)
12. Vivès, E., Schmidt, J., and Pèlegrin, A. (2008) Cell-penetrating and cell-targeting peptides in drug delivery Biochim. Biophys. Acta 1786, 126-138
13. Fonseca, S. B., Pereira, M. P., and Kelley, S. O. (2009) Recent advances in the use of cell-penetrating peptides for medical and biological applications Adv. Drug Delivery Rev. 61, 953-964
14. Myrberg, H., Zhang, L., Mäe, M., and Langel, U. (2008) Design of a tumor-homing cell-penetrating peptide Bioconjugate Chem. 19, 70-75 (Pubitemid 351213837)
15. Jiang, T., Olson, E. S., Nguyen, Q. T., Roy, M., Jennings, P. A., and Tsien, R. Y. (2004) Tumor imaging by means of proteolytic activation of cell-penetrating peptides Proc. Natl. Acad. Sci. U. S. A. 101, 17867-17872 (Pubitemid 40051978)
16. Sethuraman, V. A. and Bae, Y. H. (2007) TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors J. Controlled Release 118, 216-224 (Pubitemid 46350711)
17. Olson, E. S., Aguilera, T. A., Jiang, T., Ellies, L. G., Nguyen, Q. T., Wong, E. H., Gross, L. A., and Tsien, R. Y. (2009) In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer Integr. Biol. (Camb.) 1, 382-393
18. Nguyen, Q. T., Olson, E. S., Aguilera, T. A., Jiang, T., Scadeng, M., Ellies, L. G., and Tsien, R. Y. (2010) Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival Proc. Natl. Acad. Sci. U. S. A. 107, 4317-4322
19. Shamay, Y., Adar, L., Ashkenasy, G., and David, A. (2011) Light induced drug delivery into cancer cells Biomaterials 32, 1377-1386
20. El-Andaloussi, S., Järver, P., Johansson, H. J., and Langel, U. (2007) Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study Biochem. J. 407, 285-292 (Pubitemid 47556993)
21. Henne, W. A., Doorneweerd, D. D., Hilgenbrink, A. R., Kularatne, S. A., and Low, P. S. (2006) Synthesis and activity of a folate peptide camptothecin prodrug Bioorg. Med. Chem. Lett. 16, 5350-5355 (Pubitemid 44332214)
22. Yandek, L. E., Pokorny, A., Florén, A., Knoelke, K., Langel, U., and Almeida, P. F. (2007) Mechanism of the cell-penetrating peptide transportan 10 permeation of lipid bilayers Biophys. J. 92, 2434-2444 (Pubitemid 46536425)
23. Midoux, P., Kichler, A., Boutin, V., Maurizot, J. C., and Monsigny, M. (1998) Membrane permeabilization and efficient gene transfer by a peptide containing several histidines Bioconjugate Chem. 9, 260-267 (Pubitemid 28147145)
24. Tu, Z., Volk, M., Shah, K., Clerkin, K., and Liang, J. F. (2009) Constructing bioactive peptides with pH-dependent activities Peptides 30, 1523-1528
25. Li, L., He, J., Eckert, R., Yarbrough, D., Lux, R., Anderson, M., and Shi, W. (2010) Design and characterization of an acid-activated antimicrobial peptide Chem. Biol. Drug Des. 75, 127-132
26. Venditto, V. J. and Simanek, E. E. (2010) Cancer therapies utilizing the camptothecins: a review of the in vivo literature Mol. Pharmaceutics 7, 307-349
27. Saito, G., Swanson, J. A., and Lee, K. D. (2003) Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities Adv. Drug Delivery Rev. 55, 199-215 (Pubitemid 36135916)
28. El-Aneed, A. (2004) An overview of current delivery systems in cancer gene therapy J. Controlled Release 94, 1-14 (Pubitemid 37542373)
29. Burke, P. J., Senter, P. D., Meyer, D. W., Miyamoto, J. B., Anderson, M., Toki, B. E., Manikumar, G., Wani, M. C., Kroll, D. J., and Jeffrey, S. C. (2009) Design, synthesis, and biological evaluation of antibody-drug conjugates comprised of potent camptothecin analogues Bioconjugate Chem. 20, 1242-1250
30. 3 integrin ligands: An approach to tumor-targeted therapy Bioconjugate Chem. 21, 1956-1967